New England Research & Management, Inc. Novartis Ag Transaction History

New England Research & Management, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$92.57 - $107.37 $9,257 - $10,737	-100 Reduced 3.71%	2,595 $276,000
Q3 2023 Oct 10, 2023	BUY	$94.73 - $105.13 $255,297 - $283,325	2,695 New	2,695 $275,000
Q4 2020 Jan 07, 2021	SELL	$78.07 - $94.43 $980,403 - $1.19 Million	-12,558 Closed	0 $0
Q3 2020 Oct 08, 2020	SELL	$82.14 - $91.0 $9,199 - $10,192	-112 Reduced 0.88%	12,558 $1.09 Million
Q2 2020 Jul 15, 2020	BUY	$80.93 - $91.1 $84,976 - $95,655	1,050 Added 9.04%	12,670 $1.11 Million
Q1 2020 Jun 15, 2020	BUY	$70.67 - $99.01 $821,185 - $1.15 Million	11,620 New	11,620 $958,000
Q2 2019 Jul 09, 2019	SELL	$75.4 - $92.8 $198,302 - $244,064	-2,630 Closed	0 $0
Q1 2019 Apr 03, 2019	SELL	$75.32 - $86.15 $7,531 - $8,615	-100 Reduced 3.66%	2,630 $253,000
Q4 2018 Jan 11, 2019	SELL	$73.66 - $82.02 $3,683 - $4,101	-50 Reduced 1.8%	2,730 $234,000
Q2 2018 Jul 05, 2018	SELL	$64.91 - $73.36 $24,341 - $27,510	-375 Reduced 11.89%	2,780 $210,000
Q1 2018 Apr 17, 2018	SELL	$70.39 - $84.15 $21,117 - $25,245	-300 Reduced 8.68%	3,155 $255,000
Q4 2017 Jan 09, 2018	SELL	$72.33 - $77.64 $325,123 - $348,991	-4,495 Reduced 56.54%	3,455 $290,000
Q3 2017 Oct 25, 2017	BUY	$74.14 - $77.27 $589,413 - $614,296	7,950	7,950 $683,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

Stay updated on New England Research & Management, Inc. with notifications on news.